BIIB vs COUR · P/E 21, rev $9.89B vs rev $494.3M
Biogen Inc (BIIB) versus Coursera Inc (COUR) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Coursera Inc (COUR) is a education & training services company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported COUR revenue for 2026-06-30 was $494.3M. Net income was -$100.9M. COUR currently screens at market cap $1.35B.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. COUR currently screens at market cap $1.35B.
Not investment advice. Open the BIIB and COUR stock pages for the full models.
Not investment advice.